Alessia Pin

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Dendritic Cells

Signaling Pathway

Disease Activity

Systemic Lupus Erythematosus

Top Venues

Diagnostics (Basel, Switzerland)

International journal of environmental research and public health

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Boz, Alessandra Tesser, Martina Girardelli, Francesca Burlo, Alessia Pin, Giovanni Maria Severini, Ginevra De Marchi, Federico Verzegnassi, Samuele Naviglio, Alberto Tommasini, Erica Valencic
Inborn Errors of Immunity in Children with Autoimmune and Allergic Complaints: A Single Center Experience from Diagnosis to Treatment. Biomedicines 11 (5) (2023)
Alessandra Tesser, Alessia Pin, Elisabetta Mencaroni, Virginia Gulino, Alberto Tommasini
Vasculitis, Autoimmunity, and Cytokines: How the Immune System Can Harm the Brain. International journal of environmental research and public health 18 (11) (2021)
Alessandra Tesser, Giulia Maria Piperno, Alessia Pin, Elisa Piscianz, Valentina Boz, Federica Benvenuti, Alberto Tommasini
Priming of the cGAS-STING-TBK1 Pathway Enhances LPS-Induced Release of Type I Interferons. Cells 10 (4) (2021)
Francesco Rispoli, Erica Valencic, Martina Girardelli, Alessia Pin, Alessandra Tesser, Elisa Piscianz, Valentina Boz, Flavio Faletra, Giovanni Maria Severini, Andrea Taddio, Alberto Tommasini
Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies. Diagnostics (Basel, Switzerland) 11 (3) (2021)
Alessia Pin, Alessandra Tesser, Serena Pastore, Valentina Moressa, Erica Valencic, Anna Arbo, Alessandra Maestro, Alberto Tommasini, Andrea Taddio
Biological and Clinical Changes in a Pediatric Series Treated with Off-Label JAK Inhibitors. International journal of molecular sciences 21 (20) (2020)
Alessia Pin, Lorenzo Monasta, Andrea Taddio, Elisa Piscianz, Alberto Tommasini, Alessandra Tesser
An Easy and Reliable Strategy for Making Type I Interferon Signature Analysis Comparable among Research Centers. Diagnostics (Basel, Switzerland) 9 (3) (2019)